A novel mortality risk score for emphysematous pyelonephritis: A multicenter study of the Global Research in the Emphysematous Pyelonephritis group
Authors:
- Hegel Trujillo-SantamaríaHTHegel Trujillo-Santamaría
- José Iván Robles-TorresJRJosé Iván Robles-Torres
- Jeremy Yuen-Chun TeohJeremy Yuen-Chun Teoh
- Yiloren TanidirYTYiloren Tanidir
- José Gadú Campos-SalcedoJCJosé Gadú Campos-Salcedo
- Edgar Iván Bravo-CastroEBEdgar Iván Bravo-Castro
- Marcelo Langer WroclawskiMWMarcelo Langer Wroclawski
- W. S. YeohWYW. S. Yeoh
- Santosh KumarSKSantosh Kumar
- Juan Eduardo Sanchez-NuñezJSJuan Eduardo Sanchez-Nuñez
- José Enrique Espinoza-AznarJEJosé Enrique Espinoza-Aznar
- Deepak RagooriDRDeepak Ragoori
Open Access
- 21 November 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Current Urology
- Vol. 18 (1) , 55-60
Abstract
Background: Emphysematous pyelonephritis (EPN) is a necrotizing infection of the kidney and the surrounding tissues associated with considerable mortality. We aimed to formulate a score that classifies the risk of mortality in patients with EPN at hospital admission. Materials and methods: Patients diagnosed with EPN between 2013 and 2020 were retrospectively included. Data from 15 centers (70%) were used to develop the scoring system, and data from 7 centers (30%) were used to validate it. Univariable and multivariable logistic regression analyses were performed to identify independent factors related to mortality. Receiver operating characteristic curve analysis was performed to construct the scoring system and calculate the risk of mortality. A standardized regression coefficient was used to quantify the discriminating power of each factor to convert the individual coefficients into points. The area under the curve was used to quantify the scoring system performance. An 8-point scoring system for the mortality risk was created (range, 0–7). Results: In total, 570 patients were included (400 in the test group and 170 in the validation group). Independent predictors of mortality in the multivariable logistic regression were included in the scoring system: quick Sepsis-related Organ Failure Assessment score ≥2 (2 points), anemia, paranephric gas extension, leukocyte count >22,000/μL, thrombocytopenia, and hyperglycemia (1 point each). The mortality rate was <5% for scores ≤3, 83.3% for scores 6, and 100% for scores 7. The area under the curve was 0.90 (95% confidence interval, 0.84–0.95) for test and 0.91 (95% confidence interval, 0.84–0.97) for the validation group. Conclusions: Our score predicts the risk of mortality in patients with EPN at presentation and may help clinicians identify patients at a higher risk of death.Keywords
This publication has 27 references indexed in Scilit:
- Emphysematous Pyelonephritis: Multicenter Clinical and Therapeutic Experience in MexicoUrology, 2014
- The Central Role of Prognosis in Clinical Decision MakingJAMA, 2012
- Consensus Statement on the Adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in Clinical Microbiology Laboratories in TaiwanJournal of Microbiology, Immunology and Infection, 2010
- Emphysematous pyelonephritisBJU International, 2010
- Renal allograft failure due to emphysematous pyelonephritis: successful non-operative management and proposed new classification scheme based on literature reviewTransplant Infectious Disease, 2010
- Retrospective analysis of clinical profile prognostic factors and outcomes of 19 patients of emphysematous pyelonephritisInternational Urology and Nephrology, 2009
- Emphysematous Pyelonephritis: Outcome of Conservative ManagementUrology, 2008
- Severe Emphysematous Pyelonephritis in Diabetic PatientsUrologia Internationalis, 2005
- Emphysematous PyelonephritisArchives of internal medicine (1960), 2000
- RENAL EMPHYSEMAAmerican Journal of Roentgenology, 1970